Detalhe da pesquisa
1.
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.
Breast Cancer Res Treat
; 188(2): 465-476, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097174
2.
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.
Breast Cancer Res Treat
; 174(3): 731-740, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30656459
3.
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells.
Cancer Discov
; 14(5): 866-889, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527495
4.
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.
JCO Precis Oncol
; 8: e2300456, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691816
5.
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life.
Breast
; 70: 32-40, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300986
6.
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.
Clin Cancer Res
; 25(14): 4255-4263, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992300
7.
Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells.
Sci Data
; 4: 170020, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28248920
8.
Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production.
J Steroid Biochem Mol Biol
; 94(1-3): 159-65, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15862961
9.
Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.
Cancer Res
; 74(1): 287-97, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240700
10.
BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency.
Clin Cancer Res
; 19(18): 5003-15, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23881923
11.
A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity.
PLoS One
; 8(4): e61520, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23634208
12.
The promise of combining inhibition of PI3K and PARP as cancer therapy.
Cancer Discov
; 2(11): 982-4, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23148373
13.
Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements.
BMC Res Notes
; 5: 648, 2012 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23171647
14.
Synthetic lethal approaches to breast cancer therapy.
Nat Rev Clin Oncol
; 7(12): 718-24, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20956981
15.
ASA404: update on drug development.
Expert Opin Investig Drugs
; 17(10): 1547-51, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18808313